DESPAXOR^®(desvenlafaxine, as succinate)SYNCOHK Reg. No. HK-68803, HK-68804 (07 Aug, 2025)

Composition:¹

• DESPAXOR is available in the following dosage forms: 50 mg and 100 mg extended-release oral tablets

• Each tablet contains 76 mg or 152 mg of desvenlafaxine succinate equivalent to 50 mg or 100 mg of desvenlafaxine, respectively

Indication:¹

• A serotonin and norepinephrine reuptake inhibitor (SNRI), indicated for the treatment of adults with majordepressive disorder (MDD)

References1. Drugs.com. Desvenlafaxine ER Tablets: Package Insert / Prescribing Info. 5 August 2025. Available from: https://www.drugs.com/pro/desvenlafaxine-er-tablets.html. [Accessed 18 September 2025].